| HGNC approved symbol | HGNC ID | HGNC approved name | Entrez gene ID | UniProt AC (human) | UniProt ID (human) | Pfam domains | MGI symbol | MGI ID | UniProt AC (mouse) | UniProt ID (mouse) | HGNC gene family tag | HGNC gene family description | Function | Modification | PMID for information on function | Protein complex | Target molecule | Target entity | Product | PMID for information on target | Comment | Status of entry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
C14orf169
(details) |
20968 | # | # | Q9H6W3 | NO66_HUMAN | JmjC_2 PF08007 298-427, RIOX1_C_WH PF21233 511-637 | - | - | Q9JJF3 | NO66_MOUSE | # | # | Histone modification erase | Histone methylation | 23160351 | # | histone | H3K4me3, H3K4me1, H3K36me2 | H3K4me2, H3K4, H3K36me1 | 23160351 | H3K4me3 demethylase Rbp2 (Kdm5a). In addition to NO66=C14orf169, at least four other H3K36me3 demethylases are known. | # |
|
EHMT1
(details) |
24650 | euchromatic histone-lysine N-methyltransferase 1 | 79813 | Q9H9B1 | EHMT1_HUMAN | EHMT1-2_CRR PF21533 539-633, Ank_4 PF13637 772-836, Ank_2 PF12796 838-904 907-990, Pre-SET PF05033 1015-1118, SET PF00856 1137-1243 | Ehmt1 | 1924933 | Q5DW34 | EHMT1_MOUSE | KMT, ANKRD | Chromatin-modifying enzymes / K-methyltransferases, Ankyrin repeat domain containing | Histone modification write | Histone methylation | 18264113 | # | histone | H3K9 | H3K9me1, H3K9me2 | 18264113 | G9a and G9a-like protein (GLP)=EHMT1 are euchromatin-associated methyltransferases that repress transcription by mono- and dimethylating histone H3 at Lys9 (H3K9). | # |
|
EHMT2
(details) |
14129 | euchromatic histone-lysine N-methyltransferase 2 | 10919 | Q96KQ7 | EHMT2_HUMAN | EHMT1-2_CRR PF21533 447-540, Ank_2 PF12796 655-746 750-816, Ank PF00023 850-882, Pre-SET PF05033 927-1030, SET PF00856 1049-1155 | Ehmt2 | 2148922 | Q9Z148 | EHMT2_MOUSE | KMT, ANKRD | Chromatin-modifying enzymes / K-methyltransferases, Ankyrin repeat domain containing | Histone modification write | Histone methylation | 18264113 | # | histone | H3K9 | H3K9me1, H3K9me2 | 18264113 | G9a=EHMT2 and G9a-like protein (GLP) are euchromatin-associated methyltransferases that repress transcription by mono- and dimethylating histone H3 at Lys9 (H3K9). | # |
|
EZH1
(details) |
3526 | enhancer of zeste 1 polycomb repressive complex 2 subunit | 2145 | Q92800 | EZH1_HUMAN | EZH2_WD-Binding PF11616 39-68, PRC2_HTH_1 PF18118 160-262, Ezh2_MCSS PF21358 267-322, preSET_CXC PF18264 560-591, SET PF00856 624-727 | Ezh1 | 1097695 | P70351 | EZH1_MOUSE | KMT | Chromatin-modifying enzymes / K-methyltransferases | Histone modification write, Polycomb group (PcG) protein | Histone methylation | 19026781 | PRC2 | histone | H3K27 | H3K27me1, H3K27me2, H3K27me3 | 19026781 | Polycomb group proteins are critical to maintaining gene repression established during Drosophila development. Part of this group forms the PRC2 complex containing Ez that catalyzes di- and trimethylation of histone H3 lysine 27 (H3K37me2/3), marks repressive to transcription. The mammalian homologs Ezh1 and Ezh2 form similar PRC2 complexes but exhibit contrasting repressive roles. While PRC2-Ezh2 catalyzes H3K27me2/3 and its knockdown affects global H3K27me2/3 levels, PRC2-Ezh1 performs this function weakly. | # |
|
EZH2
(details) |
3527 | enhancer of zeste 2 polycomb repressive complex 2 subunit | 2146 | Q15910 | EZH2_HUMAN | EZH2_WD-Binding PF11616 39-68, PRC2_HTH_1 PF18118 159-249, Ezh2_MCSS PF21358 259-309, preSET_CXC PF18264 559-590, SET PF00856 623-726 | Ezh2 | 107940 | Q61188 | EZH2_MOUSE | KMT | Chromatin-modifying enzymes / K-methyltransferases | Histone modification write, Polycomb group (PcG) protein | Histone methylation | 19026781 | PRC2 | histone | H3K27 | H3K27me1, H3K27me2, H3K27me3 | 19026781 | Polycomb group proteins are critical to maintaining gene repression established during Drosophila development. Part of this group forms the PRC2 complex containing Ez that catalyzes di- and trimethylation of histone H3 lysine 27 (H3K37me2/3), marks repressive to transcription. The mammalian homologs Ezh1 and Ezh2 form similar PRC2 complexes, but exhibit contrasting repressive roles. While PRC2-Ezh2 catalyzes H3K27me2/3 and its knockdown affects global H3K27me2/3 levels, PRC2-Ezh1 performs this function weakly. | # |
|
HR
(details) |
5172 | hair growth associated | 55806 | O43593 | HAIR_HUMAN | JmjC PF02373 1051-1139 | Hr | 96223 | Q61645 | HAIR_MOUSE | # | # | Histone modification erase | Histone methylation | 24334705 | # | histone | H3K9me1, H3K9me2 | H3K9 | 24334705 | HR can demethylate monomethylated or dimethylated histone H3 lysine 9 (H3K9me1 or me2). | # |
|
KDM1A
(details) |
29079 | lysine (K)-specific demethylase 1A | 23028 | O60341 | KDM1A_HUMAN | SWIRM PF04433 183-264, Amino_oxidase PF01593 288-826 | Kdm1a | 1196256 | Q6ZQ88 | KDM1A_MOUSE | KDM | Chromatin-modifying enzymes / K-demethylases | Histone modification erase | Histone methylation | 16223729 | NuRD, BHC, SCL | histone | H3K4me1, H3K4me2, H3K9me | H3K4, H3K9 | 16223729 | Human histone demethylase LSD1=KDM1A is a flavin-dependent amine oxidase that catalyzes the specific removal of methyl groups from mono- and dimethylated Lys4 of histone H3. | # |
|
KDM1B
(details) |
21577 | lysine (K)-specific demethylase 1B | 221656 | Q8NB78 | KDM1B_HUMAN | zf-CW PF07496 137-189, SWIRM PF04433 292-364, Amino_oxidase PF01593 392-819 | Kdm1b | 2145261 | Q8CIG3 | KDM1B_MOUSE | KDM | Chromatin-modifying enzymes / K-demethylases | Histone modification erase | Histone methylation | 19727073 | # | histone | H3K4me1, H3K4me2 | H3K4 | 19727073 | KDM1B is a histone H3K4 demethylase required to establish maternal genomic imprints. | # |
|
KDM3A
(details) |
20815 | lysine (K)-specific demethylase 3A | 55818 | Q9Y4C1 | KDM3A_HUMAN | domain PF22989 8-82, domain PF22988 92-182, domain PF22987 184-249, JmjC PF02373 1158-1264 | Kdm3a | 98847 | Q6PCM1 | KDM3A_MOUSE | KDM | Chromatin-modifying enzymes / K-demethylases | Histone modification erase | Histone methylation | 16603237 | # | histone | H3K9me1, H3K9me2 | H3K9 | 16603237 | JHDM2A =KDM3A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor. | # |
|
KDM3B
(details) |
1337 | lysine (K)-specific demethylase 3B | 51780 | Q7LBC6 | KDM3B_HUMAN | domain PF22989 10-83, domain PF22988 91-188, domain PF22987 189-254, JmjC PF02373 1599-1704 | Kdm3b | 1923356 | Q6ZPY7 | KDM3B_MOUSE | KDM | Chromatin-modifying enzymes / K-demethylases | Histone modification erase | Histone methylation | 16603237 | # | histone | H3K9me1, H3K9me2 | H3K9 | 16603237 | A JmjC domain-containing protein (KDM3B=JmjC domain-containing histone demethylation protein 2B), JHDM2A, which specifically demethylates mono- and dimethyl-H3K9. | # |
|
KDM4B
(details) |
29136 | lysine (K)-specific demethylase 4B | 23030 | O94953 | KDM4B_HUMAN | JmjN PF02375 16-50, JmjC PF02373 176-292, PHD_2 PF13831 754-789, zf-HC5HC2H_2 PF13832 796-907, Tudor_2 PF18104 922-956 978-1014 | Kdm4b | 2442355 | Q91VY5 | KDM4B_MOUSE | KDM, TDRD | Chromatin-modifying enzymes / K-demethylases, Tudor domain containing | Histone modification erase | Histone methylation | 16603238 | # | histone | H3K9me3 | H3K9me1, H3K9me2 | 16603238 | Human JMJD2(B, C, D) =KDM4(B, C, D) subfamily members function as trimethylation-specific demethylases, converting H3-K9Me3 to H3-K9Me2 and H3-K9Me1, respectively. | # |
|
KDM4C
(details) |
17071 | lysine (K)-specific demethylase 4C | 23081 | Q9H3R0 | KDM4C_HUMAN | JmjN PF02375 17-51, JmjC PF02373 177-293, PHD_2 PF13831 712-747, zf-HC5HC2H_2 PF13832 754-864, Tudor_2 PF18104 881-916 939-974 | Kdm4c | 1924054 | Q8VCD7 | KDM4C_MOUSE | KDM, TDRD | Chromatin-modifying enzymes / K-demethylases, Tudor domain containing | Histone modification erase | Histone methylation | 16603238 | # | histone | H3K9me3, H3K36me3 | H3K9me1, H3K9me2 | 16603238 | Human JMJD2(B, C, D) =KDM4(B, C, D) subfamily members function as trimethylation-specific demethylases, converting H3-K9Me3 to H3-K9Me2 and H3-K9Me1, respectively. | # |
|
KDM4D
(details) |
25498 | lysine (K)-specific demethylase 4D | 55693 | Q6B0I6 | KDM4D_HUMAN | JmjN PF02375 19-53, JmjC PF02373 179-295 | Kdm4d | 3606484 | Q3U2K5 | KDM4D_MOUSE | KDM | Chromatin-modifying enzymes / K-demethylases | Histone modification erase | Histone methylation | 16603238 | # | histone | H3K9me3 | H3K9me1, H3K9me2 | 16603238 | Human JMJD2(B, C, D) =KDM4(B, C, D) subfamily members function as trimethylation-specific demethylases, converting H3-K9Me3 to H3-K9Me2 and H3-K9Me1, respectively. | # |
|
KDM5C
(details) |
11114 | lysine (K)-specific demethylase 5C | 8242 | P41229 | KDM5C_HUMAN | JmjN PF02375 15-48, ARID PF01388 80-165, PHD PF00628 327-371, JmjC PF02373 501-617, KDM5_C-hel PF21323 621-675, zf-C5HC2 PF02928 707-759, PLU-1 PF08429 771-1098 | Kdm5c | 99781 | P41230 | KDM5C_MOUSE | KDM, PHF | Chromatin-modifying enzymes / K-demethylases, Zinc fingers, PHD-type | Histone modification erase | Histone methylation | 17320160 | # | histone | H3K4me3 | H3K4me2, H3K4me1 | 17320160 | The X-linked mental retardation (XLMR) gene SMCX (JARID1C)=KDM5C, which encodes a JmjC-domain protein, reverses H3K4me3 to di- and mono- but not unmethylated products. | # |
|
KDM7A
(details) |
22224 | lysine (K)-specific demethylase 7A | 80853 | Q6ZMT4 | KDM7A_HUMAN | PHD PF00628 40-85, JmjC PF02373 269-369, JHD PF17811 373-480 | Kdm7a | 2443388 | Q3UWM4 | KDM7A_MOUSE | KDM, PHF | Chromatin-modifying enzymes / K-demethylases, Zinc fingers, PHD-type | Histone modification erase | Histone methylation | 20194436 | # | histone | H3K9me2, H3K27me2, H4K20me1 | H3K9, H3K27, H4K20 | 20194436 | KDM7 (also known as JHDM1D) is a dual demethylase for H3K9 and H3K27 that functions as an eraser of silencing marks on chromatin during brain development. Specifically binds trimethylated 'Lys-4' of histone H3 (H3K4me3), affecting histone demethylase specificity: in presence of H3K4me3, it has no demethylase activity toward H3K9me2, while it has high activity toward H3K27me2. Demethylates H3K9me2 in absence of H3K4me3. Has activity toward H4K20Me1 only when nucleosome is used as a substrate and when not histone octamer is used as substrate. | # |
|
KMT2A
(details) |
7132 | lysine (K)-specific methyltransferase 2A | 4297 | Q03164 | KMT2A_HUMAN | zf-CXXC PF02008 1149-1194, PHD PF00628 1481-1530 1569-1624, zf-HC5HC2H PF13771 1897-1978, FYRN PF05964 2016-2077, FYRC PF05965 3666-3747, SET PF00856 3840-3945 | Kmt2a | 96995 | P55200 | KMT2A_MOUSE | KMT, PHF | Chromatin-modifying enzymes / K-methyltransferases, Zinc fingers, PHD-type | Histone modification write | Histone methylation | 19187761 | MLL-HCF, CHD8, COMPASS-like MLL1,2 | histone | H3K4 | H3K4me | 19187761 | MLL1 SET domain can incorporate methyl groups into unmodified or H3K4me1 substrates, signifying both mono- and dimethylation activity. | # |
|
KMT2E
(details) |
18541 | lysine (K)-specific methyltransferase 2E | 55904 | Q8IZD2 | KMT2E_HUMAN | PHD_5 PF20826 118-164, SET PF00856 343-447 | Kmt2e | 1924825 | Q3UG20 | KMT2E_MOUSE | KMT, PHF | Chromatin-modifying enzymes / K-methyltransferases, Zinc fingers, PHD-type | Histone modification write | Histone methylation | 19377461 | # | histone | H3K4 | H3K4me1, H3K4me2 | 19377461 | Nuclear GlcNAcylation of the histone lysine methyltransferase (HKMT), MLL5, by O-GlcNAc transferase facilitates retinoic-acid-induced granulopoiesis in human HL60 promyelocytes through methylation of H3K4. | # |
|
MBTD1
(details) |
19866 | mbt domain containing 1 | 54799 | Q05BQ5 | MBTD1_HUMAN | zf-FCS_1 PF21319 52-82, MBT PF02820 189-248 289-352 388-459 496-560 | Mbtd1 | 2143977 | Q6P5G3 | MBTD1_MOUSE | # | # | Polycomb group (PcG) protein | # | 19841675 | # | histone | H4K20me1, H4K20me2 | # | 19841675 | MBTD1, Malignant Brain Tumor domain-containing protein 1, is a PcG protein. | # |
|
MSL3
(details) |
7370 | male-specific lethal 3 homolog (Drosophila) | 10943 | Q8N5Y2 | MS3L1_HUMAN | domain PF22732 11-87, MRG PF05712 161-505 | Msl3 | 1341851 | Q9WVG9 | MS3L1_MOUSE | # | # | Histone modification read | # | 20943666 | # | histone | H4K20me1 | # | 20943666 | MSL3 plays an important role in targeting the male specific lethal complex to chromatin in both humans and flies by binding to H4K20Me. | # |
|
PHF8
(details) |
20672 | PHD finger protein 8 | 23133 | Q9UPP1 | PHF8_HUMAN | PHD PF00628 44-89, JmjC PF02373 270-370, JHD PF17811 374-481 | Phf8 | 2444341 | Q80TJ7 | PHF8_MOUSE | KDM, PHF | Chromatin-modifying enzymes / K-demethylases, Zinc fingers, PHD-type | Histone modification erase | Histone methylation | 21423274 | # | histone | H3K9me1, H3K9me2, H3K27me2, H4K20me1, H3K36me2, H3K36me3, H3K4me3 | H3K9, H3K27, H4K20, H3K36, H3K4 | 21423274 | Table 1 in the reference. Via its PWWP domain it specifically binds trimethylated 'Lys-36' of histone H3 (H3K36me3): early recruitment to chromatin to be replicated allowing a quick identification of mismatch repair to initiate the DNA mismatch repair rea | # |
|
PRDM6
(details) |
9350 | PR domain containing 6 | 93166 | Q9NQX0 | PRDM6_HUMAN | PRDM2_PR PF21549 255-374, zf-C2H2 PF00096 501-523 529-551 557-577 | Prdm6 | 2684938 | Q3UZD5 | PRDM6_MOUSE | ZNF | Zinc fingers, C2H2-type | Histone modification write | Histone methylation | 17898714, 16537907 | # | histone | H3R2, H4K20 | H3R2me1, H3R2me2, H4K20me1 | 17898714, 18057026 | The arginine methyltransferase PRMT6 catalyses H3R2 di-methylation in vitro and controls global levels of H3R2me2a in vivo. H3R2 methylation by PRMT6 was prevented by the presence of H3K4me3 on the H3 tail. PRISM =PRDM6 acts as a transcriptional repressor by interacting with class I histone deacetylases and the G9a histone methyltransferase, thereby identifying PRISM as a novel SMC-restricted epigenetic regulator. | # |
|
PRMT1
(details) |
5187 | protein arginine methyltransferase 1 | 3276 | Q99873 | ANM1_HUMAN | Methyltransf_25 PF13649 92-189, domain PF22528 194-358 | Prmt1 | 107846 | Q9JIF0 | ANM1_MOUSE | PRMT | Protein arginine methyltransferases | Histone modification write | Histone methylation | 11387442 | # | histone | H4R3 | H4R3me1, H4R3me2a | 11387442 | PRMT1 specifically methylates arginine 3 (Arg 3) of H4 in vitro and in vivo. Methylation of Arg 3 by PRMT1 facilitates subsequent acetylation of H4 tails by p300. | # |
|
RBBP5
(details) |
9888 | retinoblastoma binding protein 5 | 5929 | Q15291 | RBBP5_HUMAN | WD40 PF00400 29-52 62-94 | Rbbp5 | 1918367 | Q8BX09 | RBBP5_MOUSE | WDR | WD repeat domain containing | Histone modification write cofactor | Histone methylation | 19556245 | COMPASS, Menin-associated_HMT, MLL-HCF, CHD8, MLL2/3, COMPASS-like MLL1,2, MLL4/WBP7, COMPASS-like MLL3,4 | histone | H3K4 | H3K4me1, H3K4me2, H3K4me3 | 19556245 | A five-component 200-kDa MLL1 core complex containing human MLL1, WDR5, RbBP5, Ash2L, and DPY-30. | # |
|
SETD7
(details) |
30412 | SET domain containing (lysine methyltransferase) 7 | 80854 | Q8WTS6 | SETD7_HUMAN | MORN PF02493 19-34 36-58 60-81, domain PF22648 110-184, SET PF00856 227-336 | Setd7 | 1920501 | Q8VHL1 | SETD7_MOUSE | KMT | Chromatin-modifying enzymes / K-methyltransferases | Histone modification write | Histone methylation | 11779497 | # | histone | H3K4 | H3K4me1 | 11779497 | SET7 methylates H3-K4 in vitro and in vivo. In addition, methylation of H3-K4 and H3-K9 inhibit each other. Furthermore, H3-K4 and H3-K9 methylation by SET7 and SUV39H1, respectively, have differential effects on subsequent histone acetylation by p300. May explain differential effects of H3-K4 and H3-K9 methylation on transcription. | # |
|
SETD8
(details) |
29489 | SET domain containing (lysine methyltransferase) 8 | 387893 | Q9NQR1 | SETD8_HUMAN | SET PF00856 268-378 | Setd8 | 1915206 | Q2YDW7 | SETD8_MOUSE | KMT | Chromatin-modifying enzymes / K-methyltransferases | Histone modification write | Histone methylation | 12086618 | # | histone | H4K20 | H4K20me1 | 12086618 | The encoding gene PR/SET07 =SETD8 of a human histone H4 lysine 20 methyltransferase. | # |
|
SIRT2
(details) |
10886 | sirtuin 2 | 22933 | Q8IXJ6 | SIR2_HUMAN | SIR2 PF02146 84-268 | Sirt2 | 1927664 | Q8VDQ8 | SIR2_MOUSE | # | # | Histone modification erase, Histone modification write cofactor | Histone acetylation, Histone methylation | 11427894 | # | histone | H3K18ac, H3K56ac, H4K16ac, H4K20me1 | H3K18, H3K56, H4K16, H4K20me2, H4K20me3 | 11427894 | Sir2 =SIRT2 is an NAD-dependent histone deacetylase that mediates transcriptional silencing at mating-type loci, telomeres and ribosomal gene clusters. | # |
|
SUV39H1
(details) |
11479 | suppressor of variegation 3-9 homolog 1 (Drosophila) | 6839 | O43463 | SUV91_HUMAN | Chromo PF00385 43-91, Pre-SET PF05033 141-235, SET PF00856 255-366 | Suv39h1 | 1099440 | O54864 | SUV91_MOUSE | KMT | Chromatin-modifying enzymes / K-methyltransferases | Histone modification write, Histone modification write | Histone methylation, Histone phosphorylation | 10949293 | eNoSc | histone | H3S10, H3K9me1, H4 | H3K9me3 | 10949293 | In vivo, deregulated SUV39H1 or disrupted Suv39h activity modulate H3 serine 10 phosphorylation in native chromatin and induce aberrant mitotic divisions. | # |
|
SUV39H2
(details) |
17287 | suppressor of variegation 3-9 homolog 2 (Drosophila) | 79723 | Q9H5I1 | SUV92_HUMAN | Chromo PF00385 47-95, Pre-SET PF05033 149-242, SET PF00856 262-373 | Suv39h2 | 1890396 | Q9EQQ0 | SUV92_MOUSE | KMT | Chromatin-modifying enzymes / K-methyltransferases | Histone modification write | Histone methylation | 15107829 | # | histone | H3K9me1 | H3K9me3 | 15107829 | Suv39h proteins are histone methyltransferases that methylate histone H3 on lysine 9, resulting in transcriptional repression or silencing of target genes. | # |
|
WDR5
(details) |
12757 | WD repeat domain 5 | 11091 | P61964 | WDR5_HUMAN | WD40 PF00400 38-72 78-115 119-157 161-199 203-242 246-287 292-331 | Wdr5 | 2155884 | P61965 | WDR5_MOUSE | WDR | WD repeat domain containing | Histone modification read | # | 16946699 | ATAC, NSL, RING2-L3MBTL2, COMPASS, Menin-associated_HMT, MLL-HCF, CHD8, MLL2/3, COMPASS-like MLL1,2, MLL4/WBP7, COMPASS-like MLL3,4 | histone | H3K4, H3K4me1, H3K4me2, H3K4me3 | # | 16946699 | The WD40 domain of WDR5 represents a new class of histone methyl-lysine recognition domains that is important for recruiting H3K4 methyltransferases to K4-dimethylated histone H3 tail as well as for global and gene-specific K4 trimethylation. Here is given the crystal structures of full-length WDR5, WDR5Delta23 and its complexes with unmodified, mono-, di- and trimethylated histone H3K4 peptides. | # |